Prions and their partners in crime
The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Prions, the infectious agents of transmissible spongiform encephalopathies (TSEs), have defied full characterization for decades. The dogma has been that prions lack nucleic acids and are composed of a pathological, self-inducing form of the host's prion protein (PrP). Recent progress in propagating TSE infectivity in cell-free systems has effectively ruled out the involvement of foreign nucleic acids. However, host-derived nucleic acids or other non-PrP molecules seem to be crucial. Interactions between TSE-associated PrP and its normal counterpart are also pathologically important, so the physiological functions of normal PrP and how they might be corrupted by TSE infections have been the subject of recent research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PrPSc levels are in many cases poorly correlated with prion disease progression, suggesting that it is necessary but not sufficient; ‘something else’ is required”
Citations
Cites
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Self-citationThe cellular prion protein binds copper in vivo
Brown, D. R., Qin, K., Herms, J. W., Madlung, A., Manson, J., Strome, R., Fraser, P. E., Kruck, T., von Bohlen, A., Schulz-Schaeffer, W., et al. (1997) · Nature · doi:10.1038/37783 · Cited by 1,273
Legname, G., Baskakov, I. V., Nguyen, H.-O. B., Riesner, D., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (2004) · Science · doi:10.1126/science.1100195 · Cited by 1,021 · cited 1×
“One team showed that synthetic truncated PrP fibril preparations can induce TSE disease when inoculated into transgenic mice that vastly overexpress the same truncated PrP construc”
BackgroundCells release prions in association with exosomes
Fevrier, B., Vilette, D., Archer, F., Loew, D., Faigle, W., Vidal, M., Laude, H., & Raposo, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308413101 · Cited by 997
S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration
Uehara, T., Nakamura, T., Yao, D., Shi, Z.-Q., Gu, Z., Ma, Y., Masliah, E., Nomura, Y., & Lipton, S. A. (2006) · Nature · doi:10.1038/nature04782 · Cited by 906
The most infectious prion protein particles
Silveira, J. R., Raymond, G. J., Hughson, A. G., Race, R. E., Sim, V. L., Hayes, S. F., & Caughey, B. (2005) · Nature · doi:10.1038/nature03989 · Cited by 899 · cited 2×
“To better characterize the minimal infectious unit and the most infectious particles per unit protein, Silveira et al.(17) developed new methods for gently disaggregating scrapie prion aggregates in detergent and separating them by size using flow field-flow fractionation.”
MethodSelf-citationNormal host prion protein necessary for scrapie-induced neurotoxicity
Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., & Aguzzi, A. (1996) · Nature · doi:10.1038/379339a0 · Cited by 810 · cited 1×
“This is consistent with earlier studies that described reduced PrPres-induced neuropathology in brain tissue that lacks PrP C (ref”
ResultPrion protein is necessary for normal synaptic function
Collinge, J., Whittington, M. A., Sidle, K. C. L., Smith, C. J., Palmer, M. S., Clarke, A. R., & Jefferys, J. G. R. (1994) · Nature · doi:10.1038/370295a0 · Cited by 799
In Vitro Generation of Infectious Scrapie Prions
Castilla, J., Saá, P., Hetz, C., & Soto, C. (2005) · Cell · doi:10.1016/j.cell.2005.02.011 · Cited by 790 · cited 1×
“have demonstrated the cell-free propagation of PrPres and accompanying robust TSE infectivity, but many molecules besides PrP were also presen”
BackgroundDepleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis
Mallucci, G., Dickinson, A., Linehan, J., Klöhn, P.-C., Brandner, S., & Collinge, J. (2003) · Science · doi:10.1126/science.1090187 · Cited by 770
Research works printed but not linked: 1
- Ben-Zaken, O. et al. Cellular heparan sulfate participates in the metabolism of prions. J. Biol. Chem. 278, 40041–40049 (2003). · DOI · Paper page
Cited by
Items 201–294 of 294
Medicinal Chemistry of Hybrids for Neurodegenerative Diseases
Uliassi, E., Prati, F., Bongarzone, S., & Bolognesi, M. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-101011-2.00010-6 · Cited by 15
Prion protein—Semisynthetic prion protein (PrP) variants with posttranslational modifications
Hackl, S., & Becker, C. F. W. (2019) · Journal of Peptide Science · doi:10.1002/psc.3216 · Cited by 9
Austbø, L., Espenes, A., Olsaker, I., Press, C. M., & Skretting, G. (2007) · Journal of General Virology · doi:10.1099/vir.0.82791-0 · Cited by 9
“The findings of the present study suggest that high levels of PrP mRNA expression in cells or in a tissue do not imply accumulation of PrPSc in that same tissue and it is likely that other factors are involved in the accumulation of PrPSc (Caughey & Baron, 2006).”
BackgroundTherapeutic development of polymers for prion disease
Teruya, K., & Doh‐ura, K. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03604-1 · Cited by 8
“Analysis of the anti-prion mechanism of polyanions has revealed direct interactions between PrP and glucosaminoglycans (GAGs) (Caughey and Baron 2006).”
BackgroundSwayampakula, M., Baral, P. K., Aguzzi, A., Kav, N. N. V., & James, M. N. G. (2013) · Protein Science · doi:10.1002/pro.2270 · Cited by 8
“Several studies on potential biological binding partners of the OR domain showed that along with its flanking residues, it binds to a variety of ligands such as copper, zinc, sulfated aminoglycans, hemin, nucleic acids, stress inducible protein1, the laminin receptor, and the Low-density lipoprotein (LDL) receptor.(11)”
BackgroundAgnati, L. F., Leo, G., Genedani, S., Piron, L., Rivera, A., Guidolin, D., & Fuxé, K. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0150-4 · Cited by 8
Baillod, P., Garrec, J., Tavernelli, I., & Röthlisberger, U. (2013) · Biochemistry · doi:10.1021/bi400884e · Cited by 8
Protein-Based Neuropathology and Molecular Classification of Human Neurodegenerative Diseases
Kovács, G. G., & Budka, H. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_11 · Cited by 10
“Possible functions comprise a role in neurogenesis and differentiation of neural stem cells, neuritogenesis, synaptogenesis, neuronal survival via anti or pro-apoptotic functions, copper binding, redox homeostasis, long term renewal of haematopoetic stem cells, activation and development of T cells, differentiation, m…”
BackgroundAll quiet on the neuronal front: NMDA receptor inhibition by prion protein
Steele, A. D. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200803152 · Cited by 8
“Several investigators suggest that the study of PrP ’ s normal function may shed light on the pathogenic sequelae of prion disease (for reviews see Caughey and Baron, 2006 ; Steele et al., 2007a ).”
BackgroundNo more brain tangles with ΔNp73
Mattson, M. P., & Ashery, U. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.10.004 · Cited by 8
Teruya, K., Wakao, M., Sato, M., Hamanaka, T., Nishizawa, K., Funayama, Y., Sakasegawa, Y., Suda, Y., & Doh‐ura, K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.139 · Cited by 7
“Previous studies have suggested that glycosaminoglycans (GAGs), which exist endogenously on the cell surface and extracellular matrix, play important roles in prion formation and infection [2].”
BackgroundPredicting the aggregation propensity of prion sequences
Espargaró, A., Busquets, M. A., Estelrich, J., & Sabaté, R. (2015) · Virus Research · doi:10.1016/j.virusres.2015.03.001 · Cited by 7
Gubbins, S., Touzeau, S., & Hagenaars, T. J. (2010) · Veterinary Research · doi:10.1051/vetres/2010014 · Cited by 7
“Finally, the routes of transmission have yet to be elucidated [10, 11, 42], and, indeed, the infectious agent has yet to be fully characterised [7, 11].”
BackgroundSingh, J. P., Whitford, P. C., Hayre, N. R., Onuchic, J. N., & Cox, D. L. (2012) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24026 · Cited by 7
Detection of chronic wasting disease prions in the farm soil of the Republic of Korea
Park, K., Park, H., Lee, Y., Mitchell, G. B., Choi, Y. P., & Sohn, H. (2025) · mSphere · doi:10.1128/msphere.00866-24 · Cited by 6
“and pathological isoform (PrP Sc ) (3, 4).”
Expression of prion gene and presence of prion protein during development of mouse molar tooth germ
Khan, Q., Press, C. M., Sehic, A., Landin, M. A., Risnes, S., & Osmundsen, H. (2010) · European Journal Of Oral Sciences · doi:10.1111/j.1600-0722.2010.00783.x · Cited by 6
Jeffrey, M., Scholes, S. F. E., Мартин, С., McGovern, G., Sisó, S., & González, L. (2011) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2011.08.011 · Cited by 6
Involvement of Endogenous Retroviruses in Prion Diseases
Lee, Y.-J., Jeong, B., Choi, E., & Kim, Y. (2013) · Pathogens · doi:10.3390/pathogens2030533 · Cited by 7
“considered as candidate catalysts for PrP conversion in the host [7–11].”
BackgroundDistribution of the cellular prion protein in the central nervous system of the chicken
Atoji, Y., & Ishiguro, N. (2009) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2009.09.001 · Cited by 6
Serum Nucleic Acids in an Experimental Bovine Transmissible Spongiform Encephalopathy Model
Beck, J., Urnovitz, H. B., Groschup, M. H., Ziegler, U., Brenig, B., & Schütz, E. (2009) · Zoonoses and Public Health · doi:10.1111/j.1863-2378.2009.01260.x · Cited by 6
“However, the protein-only hypothesis, which dominates the field, has been called into question as no report provides conclusive evidence that the infectious agent is solely composed of misfolded prion protein (Caughey and Baron, 2006).”
BackgroundRigidifying the β2−α2 Loop in the Mouse Prion Protein Slows down Formation of Misfolded Oligomers
Pal, S., & Udgaonkar, J. B. (2024) · Biochemistry · doi:10.1021/acs.biochem.4c00435 · Cited by 5
Ochsner, S. A., & McKenna, N. J. (2020) · Thyroid · doi:10.1089/thy.2019.0307 · Cited by 6
“Other TR TC90 transcripts with documented connections to neurodegenerative diseases include: Atxn1, human mutations in which have been associated with spinocerebellar ataxia, characterized by progressive loss of cerebellar neurons (52); Park7, defects in which are implicated in Parkinson’s disease (53); and the prion…”
BackgroundSecretin receptor involvement in prion‐infected cells and animals
Kimura, T., Nishizawa, K., Oguma, A., Nishimura, Y., Sakasegawa, Y., Teruya, K., Nishijima, I., & Doh‐ura, K. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.039 · Cited by 5
Amyloids in solid-state nuclear magnetic resonance: potential causes of the usually low resolution
Sabaté, R., Espargaró, A., Busquets, M. A., & Estelrich, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s89385 · Cited by 5
Endogenous Viral Etiology of Prion DiseasesPreprint
BANDEA, C. I. (2009) · Nature Precedings · doi:10.1038/npre.2009.3887.1 · Cited by 6
Nouvelles formes de maladies à prions chez les ruminants
Laude, H., & Béringue, V. (2008) · Pathologie Biologie · doi:10.1016/j.patbio.2008.07.023 · Cited by 4
Disease‐associated prion protein is not detectable in human systemic amyloid deposits
Tennent, G. A., Head, M. W., Bishop, M. D., Hawkins, P. N., Will, R. G., Knight, R., Peden, A., McCardle, L., Ironside, J. W., & Pepys, M. B. (2007) · The Journal of Pathology · doi:10.1002/path.2240 · Cited by 4
“Nevertheless, all, or nearly all, forms of TSE are associated with the accumulation of PrPSc [2–4], although the precise molecular PrP conformations associated with infectivity are still poorly defined [8].”
BackgroundPolido, S. A., Kamps, J., & Tatzelt, J. (2021) · Biomolecules · doi:10.3390/biom11081201 · Cited by 5
Martin, R., Chantepie, S., Chapuis, J., Le-Duc, A., Maftah, A. A., Papy-García, D., Laude, H., Petit, J., & Gallet, P. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.126 · Cited by 4
Contrasting roles of autophagy in cellular prion infection
Abdulrahman, B., Heiseke, A., Aguib, Y., Li, L., Abdelaziz, D. H., Ansari, M., Thapa, S., Taguchi, Y., Gilch, S., & Schätzl, H. M. (2025) · Autophagy · doi:10.1080/15548627.2025.2545604 · Cited by 4
“In contrast, PK-resistant PRNP is infectious, aggregated, and partly resistant to proteolytic digestion by the proteinase K (PK) enzyme [12].”
Garth, F. (2011) · InTech eBooks · doi:10.5772/27973 · Cited by 6
“associate with membranes (29, 40, 53, 67, 173, 230, 233) and bind to membrane associated”
BackgroundSikorska, B., Liberski, P. P., & Brown, P. (2008) · PubMed · Cited by 3
Review: The Prion and its Potentiality
Dipendra Raj, P., eya, Acharya, N. K., & Hong, S. (2010) · Rowan Digitals Works (Rowan University) · Cited by 3
Honda, R. P. (2018) · Angewandte Chemie · doi:10.1002/ange.201800197 · Cited by 3
Marzola, G. P., Abuna, R. P. F., Ribeiro, L. D. A., Parra, J. P. R. L. L., Garcia, M. H. H., Barbalho, S. M., & Miglino, M. A. (2026) · Veterinary Sciences · doi:10.3390/vetsci13040398 · Cited by 3
“Beyond the nervous system, additional activities have been suggested, including immune regulation and copper binding [52].”
Human Lactoferrin Biopharming in New Zealand Scientific Risk Assessement
Heinemann, J. A. (2008) · Cited by 2
Response to Radulescu and Brenig: Infectious nucleic acids in prion disease: halfway there
Silva, J. L., Lima, L. M. T. R., Foguel, D., & Cordeiro, Y. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.10.001 · Cited by 2
Physical, chemical and kinetic factors affecting prion infectivity
Properzi, F., Badhan, A., Klier, S., Schmidt, C., Klöhn, P., Wadsworth, J. D. F., Clarke, A. R., Jackson, G. S., & Collinge, J. (2016) · Prion · doi:10.1080/19336896.2016.1181250 · Cited by 4
“isoform is the infectious agent acting to replicate itself with high fidelity by recruiting endogenous PrP and that the difference between these isoforms lies purely in the monomer conformation and its state of aggregation.(1,2,4,6-10) However, prion-diseased brain contains a highly heterogeneous population of abnorma…”
BackgroundCohen, N. P., Presti, E. L., Dell’Acqua, S., Jantz, T., Shimon, L. J. W., Levy, N., Nassir, M., Elbaz, L., Casella, L., & Fischer, B. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b00287 · Cited by 2
Sack, G. H. (2009) · Springer eBooks · doi:10.1007/978-1-84800-934-9_46 · Cited by 2
Infectious disease - developments in the field of Creutzfeldt-Jakob disease.
Beckham, J. D., & Tyler, K. L. (2007) · PubMed · Cited by 2
Recent developments in therapeutics for prion diseases
Sakaguchi, S. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.1.35 · Cited by 3
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice
Outeiro, T. F., Kalia, L. V., Bézard, E., Ferrario, J. E., Lin, C., Salama, M., Standaert, D. G., Taiwo, L., Takahashi, R., Vila, M., et al. (2024) · Movement Disorders · doi:10.1002/mds.29802 · Cited by 1
“25,26 Through several iterations, α Syn-SAA capable of identifying seed-competent α Syn in cerebro-spinal fl uid, skin, or blood 27 of individuals with a synucleinopathy are being established and making their path towards clinical practice.”
BackgroundNew Perspectives on Prion Conversion: Introducing a Mechanism of Deformed Templating
Baskakov, I. V. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5305-5_9 · Cited by 1
Prion Protein Misfolding at the Synapse
Šišková, Z., Perry, V. H., & Asuni, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7061-9_15 · Cited by 1
Introduction: retroviruses, DNA viruses, and prions
Reiss, C. S. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.011 · Cited by 1
Effects of FlAsH/Tetracysteine (TC) Tag on PrP Proteolysis and PrPres Formation by TC‐Scanning
Taguchi, Y., Hohsfield, L. A., Hollister, J. R., & Baron, G. S. (2013) · ChemBioChem · doi:10.1002/cbic.201300255 · Cited by 1
Self-citationLinden, R., Martins, V. R., & Prado, M. A. M. (2009) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a003935.01 · Cited by 3
Nanopore Analysis of Peptides and Proteins
Stefureac, R. I. (2012) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 1
The saga of prion: to cut or not to cut
Sy, M. (2009) · Cell Research · doi:10.1038/cr.2009.102 · Cited by 1
Heinemann, J. A. (2012) · UC Research Repository (University of Canterbury) · Cited by 1
The first step towards the development of an electrophoretic prion detector
Madampage, C. A. (2011) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 1
Transmissible Spongiform Encephalopathies of Humans and Animals
Mead, S., Collinge, J., & Tabrizi, S. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00023-x · Cited by 1
Benvegnù, S., Franciotta, D. M., Sussman, J., Bachi, A., Zardini, E., Torreri, P., Govaerts, C., Pizzo, S. V., & Legname, G. (2009) · PLoS ONE · doi:10.1371/annotation/6f581801-c5f0-4fb0-9e55-6ee35653cd12 · Cited by 1
Prions: Transmissable Spongiform Encelphalopathies and Dental Transmission Risk Assessment
Hamilton, J. (2007) · Journal of the California Dental Association · doi:10.1080/19424396.2007.12221198 · Cited by 1
Smith, P. E. S. (2010) · Deep Blue (University of Michigan)
pH modulation of fibril dissociation and copper binding properties of the prion protein
Qi, X. (2012) · ScholarWorks at University of Montana
Mechanisms of Supramolecular Assembly Exemplified by Microtubules and Amyloid Fibril Formation
Bayley, P. M. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6466-1_7
“are involved in the transmissible disease (Caughey and Baron 2006).”
Wadsworth, J. D. F., & Collinge, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02648-9
Transmissible spongiform encephalopathies
Supattapone, S., & Rees, J. R. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.017
Prion Protein Binds to Aldolase A Produced by Bovine Intestinal M Cells
Nagasawa, Y., Takahashi, Y., Itani, W., Watanabe, H., Hidaka, Y., Morita, S., Suzuki, K., Watanabe, K., Ohwada, S., Kitazawa, H., et al. (2015) · Open Journal of Veterinary Medicine · doi:10.4236/ojvm.2015.53007
“[51]-[54].”
Prion infection of ovine cell culture with a natural Swedish scrapie isolate from 1986
Ahlberg, V. (2010) · Epsilon Archive for Student Projects (University of Southampton)
Neuropathogenesis of Prion Disease
Davidson, L., & Knight, R. (2014) · Future Neurology · doi:10.2217/fnl.13.74
Water and the Biology of Prions and PlaquesPreprint
Steel, G., & Wiggins, P. (2007) · Nature Precedings · doi:10.1038/npre.2007.1381.1
Quist, D., Grønsberg, I. M., & Martin‐Armas, M. (2012)
Prion protein as an infectious agent of Transmissible Spongiform Encephalopathies
Cyranek, W. (2008) · OhioLink ETD Center (Ohio Library and Information Network)
Kollalpitiya, K. Y. (2011) · Holmes Museum Of Anthropology (Wichita State University)
Creutzfeldt–Jakob Disease and Dementia
Kovács, G. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00005-7
Binding and Dissociation of Biomarkers for Alzheimer's Disease on Biosensor Surfaces
Sadana, A., & Sadana, N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53794-2.00009-4
Protein Assembly Disorders and Protein-Based Inheritance
Rubel, A. A., Saifitdinova, A. F., & Romanova, N. V. (2016) · Springer eBooks · doi:10.1007/978-3-319-48838-7_8
Structural characterization of antibody binding to the prion protein
Swayampakula, M. (2014) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3st7f52h · Cited by 1
Neurodegenerative Disorders Progression: From Synaptic Dysfunction to Transmission Failure
Kaur, R., Kaur, H., Rajput, R., Kumar, S., Rachana, R., & Singh, M. (2018) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-5282-6.ch006
Wadsworth, J. D. F., & Collinge, J. (2008) · Elsevier eBooks · doi:10.1016/b978-012374410-4.00478-7
(2009) · Wiley eBooks · doi:10.1002/9780470551455.biblio
Cellular Prion Protein (PrPC): Identification and Characterization of Novel Interacting Partners
Zafar, S. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-519
Prion Protein and Metal Interaction: Physiological and Pathological Implications
Singh, N., Das, D., Singh, A., & Mohan, M. L. (2010) · Current Issues in Molecular Biology · doi:10.21775/cimb.012.099 · Cited by 24
Morina, R. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1912
Water and the biology of prions and plaquesPreprint
Steel, G. K., & Wiggins, P. M. (2013) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/000224
Bannach, O., & Riesner, D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378630-2.00112-2
Prion Conversion and Deformed Templating
Baskakov, I. V. (2023) · Springer eBooks · doi:10.1007/978-3-031-20565-1_5
Mouse Models of Prion Protein Related Diseases
Gasset, M., & Aguzzi, A. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00230
Britt, W. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00211-9
Reassessing late-stage impact assumptions in light of modern planet formation paradigms
Turner, B. (2026) · Frontiers in Astronomy and Space Sciences · doi:10.3389/fspas.2026.1777086
“…volatile retention, angular momentum evolution, and siderophile constraints, motivating ongoing refinements such as high-angular-momentum and synestia-type impact formulations (Wisdom, 2006; Saal et al., 2008; Ćuk and Stewart, 2012; Mastrobuono-Battisti et al., 2015; Lock and Stewart, 2017).”
Evaluation expérimentale du risque prion lié aux porteurs asymptomatiques chez l'Homme et le macaque
Rontard, J. (2018) · theses.fr (ABES) · doi:10.70675/ee7dac13zd082z49c7za670z3e9b627c4ab7 · Cited by 1
Han, Y., & He, Z. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00037-w
“It contains a flexible N-terminal intrinsically disordered region and a C-terminal globular domain composed of three α-helices and two β-strands, stabilized by a disulfide bond linking helices 2 and 3 [55].”
Kumari, P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.25.753467
Gębski, P., & Sikorska, B. (2010) · DOAJ (DOAJ: Directory of Open Access Journals)
Probing Isoforms of the Prion Protein through Tyrosine Nitration
Lennon, C. W. (2007) · The Mathematics Enthusiast
Probing Structural Differences of Recombinant Prion Isoforms Using Fluorescence Spectroscopy
Gilbert, J. L. (2008) · ScholarWorks at University of Montana
Prion Biochemistry and Therapeutics
Caughey, B. W., Sim, V. L., Taubner, L. M., Wilham, J. M., Orru, C. D., Christensen, L. B., Barton, K. L., Raymond, G. J., Raymond, L. D., & Hughson, A. G. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-512-5_31
Self-citation
Metadata
- Authors
- Caughey, B., & Baron, G. S.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Caughey, Byron
- Baron, Gerald S.
- Venue
- Nature
- Published
- 2006-10
- Volume
- 443
- Issue
- 7113
- Pages
- 803-810
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2057579163
- Cited by
- 295
- References
- 96
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 8 · 2016: 10 · 2015: 11 · 2014: 11 · 2013: 14 · 2012: 19
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- prions, prion disease, prion protein, prion pathogenesis
- MeSH terms
- Animals, Copper, Humans, Ligands, Prions, Prion Diseases, Glycosylphosphatidylinositols
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.